HK Stock Market Move | CHINARES PHARMA (03320) continues to rise by more than 4%, with a year-on-year increase in net profit of over 20%. Final dividends have doubled compared to last year.

CHINARES PHARMA (03320) rose by over 4%, reaching 4.23% at the time of publication, closing at HKD 5.18, with a turnover of HKD 96.1 million. In terms of news, CHINARES PHARMA released its annual performance, with a group revenue of RMB 269.574 billion, an increase of 4.62% year-on-year; attributable profit to shareholders of RMB 4.045 billion, an increase of 20.73% year-on-year; earnings per share of RMB 0.64; declared a final dividend of RMB 0.122, an increase of approximately 135% year-on-year. In terms of business, the pharmaceutical business revenue was RMB 51.039 billion, an increase of 10.2% year-on-year, with significant growth in the Chinese medicine, biopharmaceutical, nutritional health products and other sectors; pharmaceutical distribution business revenue was RMB 220.080 billion, an increase of 3.2% year-on-year; pharmaceutical retail business revenue was RMB 12.210 billion, an increase of 20.8% year-on-year, with rapid growth in DTP business.